A Novel Set of WNT Pathway Effectors as a Predictive Marker of Uterine Corpus Endometrial Carcinoma–Study Based on Weighted Co-expression Matrices
Uterine corpus endometrial carcinomas (UCEC) are clinically divided into two subgroups—endometrioid endometrial carcinoma (EEC) or non-endometrioid endometrial carcinoma (NEEC). The first group shows relatively better prognosis. However, the discrimination seems to be insufficient due to the fact th...
Main Authors: | Katarzyna Kośla, Magdalena Orzechowska, Dorota Jędroszka, Izabela Baryła, Andrzej K. Bednarek, Elżbieta Płuciennik |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00360/full |
Similar Items
-
The Role and Significance of Wnt5a in Regulating Epithelial–Mesenchymal Transition in Endometrioid Adenocarcinoma
by: Yang N, et al.
Published: (2021-08-01) -
Brain Metastases from Uterine Cervical and Endometrial Cancer
by: Mayumi Kobayashi Kato, et al.
Published: (2021-01-01) -
YTHDF2 is a novel diagnostic marker of endometrial adenocarcinoma and endometrial atypical hyperplasia/ intraepithelial neoplasia
by: Bian, P.-P, et al.
Published: (2022) -
Peritoneal keratin granuloma associated with endometrioid adenocarcinoma of the uterine corpus
by: Kayano Hidekazu, et al.
Published: (2011-10-01) -
Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
by: Ioannis Alagkiozidis, et al.
Published: (2015-04-01)